BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 28960322)

  • 1. Impact of intraoperative factor concentrates on blood product transfusions during orthotopic liver transplantation.
    Colavecchia AC; Cohen DA; Harris JE; Thomas JM; Lindberg S; Leveque C; Salazar E
    Transfusion; 2017 Dec; 57(12):3026-3034. PubMed ID: 28960322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of prothrombin complex concentrate as first-line treatment modality of coagulopathy in patients undergoing liver transplantation: A propensity score-matched study.
    Srivastava P; Agarwal A; Jha A; Rodricks S; Malik T; Makki K; Singhal A; Vij V
    Clin Transplant; 2018 Dec; 32(12):e13435. PubMed ID: 30375084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraoperative Administration of 4-Factor Prothrombin Complex Concentrate Reduces Blood Requirements in Cardiac Transplantation.
    Sun GH; Patel V; Moreno-Duarte I; Zahedi F; Ursprung E; Couper G; Chen FY; Welsby IJ; Comenzo R; Kao G; Cobey FC
    J Cardiothorac Vasc Anesth; 2018 Feb; 32(1):161-167. PubMed ID: 29198634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of Rotational Thromboelastometry in Liver Transplantation Is Associated With Reduced Transfusion Requirements.
    Schumacher C; Eismann H; Sieg L; Friedrich L; Scheinichen D; Vondran FWR; Johanning K
    Exp Clin Transplant; 2019 Apr; 17(2):222-230. PubMed ID: 30295585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prothrombin complex concentrate in the reduction of blood loss during orthotopic liver transplantation: PROTON-trial.
    Arshad F; Ickx B; van Beem RT; Polak W; Grüne F; Nevens F; Ilmakunnas M; Koivusalo AM; Isoniemi H; Strengers PF; Groen H; Hendriks HG; Lisman T; Pirenne J; Porte RJ
    BMC Surg; 2013 Jul; 13():22. PubMed ID: 23815798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between viscoelastic tests-guided therapy with synthetic factor concentrates and allogenic blood transfusion in liver transplantation: a before-after study.
    Zamper RPC; Amorim TC; Queiroz VNF; Lira JDO; Costa LGV; Takaoka F; Juffermans NP; Neto AS
    BMC Anesthesiol; 2018 Dec; 18(1):198. PubMed ID: 30579327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: a retrospective, single-center cohort study.
    Görlinger K; Dirkmann D; Hanke AA; Kamler M; Kottenberg E; Thielmann M; Jakob H; Peters J
    Anesthesiology; 2011 Dec; 115(6):1179-91. PubMed ID: 21970887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conjugated estrogen reduces transfusion and coagulation factor requirements in orthotopic liver transplantation.
    Frenette L; Cox J; McArdle P; Eckhoff D; Bynon S
    Anesth Analg; 1998 Jun; 86(6):1183-6. PubMed ID: 9620500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety of coagulation factor concentrates guided by ROTEM™-analyses in liver transplantation: results from 372 procedures.
    Hartmann M; Walde C; Dirkmann D; Saner FH
    BMC Anesthesiol; 2019 Jun; 19(1):97. PubMed ID: 31185916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of fibrinogen concentrate alone or with prothrombin complex concentrate (+/- fresh frozen plasma) on plasma fibrinogen level and fibrin-based clot strength (FIBTEM) in major trauma: a retrospective study.
    Schlimp CJ; Voelckel W; Inaba K; Maegele M; Schöchl H
    Scand J Trauma Resusc Emerg Med; 2013 Oct; 21():74. PubMed ID: 24103457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prothrombin Complex Concentrate Reduces Blood Product Utilization in Heart Transplantation.
    Enter DH; Zaki AL; Marsh M; Cool N; Kruse J; Li Z; Andrei AC; Iddriss A; McCarthy PM; Malaisrie SC; Anderson A; Rich JD; Pham DT
    Pharmacotherapy; 2017 Oct; 37(10):1215-1220. PubMed ID: 28833357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thromboelastometry-guided administration of fibrinogen concentrate for the treatment of excessive intraoperative bleeding in thoracoabdominal aortic aneurysm surgery.
    Rahe-Meyer N; Solomon C; Winterhalter M; Piepenbrock S; Tanaka K; Haverich A; Pichlmaier M
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):694-702. PubMed ID: 19698858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with prothrombin complex for the emergent reversal of anticoagulation in rural geriatric trauma patients.
    Quick JA; Bartels AN; Coughenour JP; Barnes SL
    Surgery; 2012 Oct; 152(4):722-6; discussion 726-8. PubMed ID: 22943840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma.
    Innerhofer P; Westermann I; Tauber H; Breitkopf R; Fries D; Kastenberger T; El Attal R; Strasak A; Mittermayr M
    Injury; 2013 Feb; 44(2):209-16. PubMed ID: 23000050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes Following Three-Factor Inactive Prothrombin Complex Concentrate Versus Recombinant Activated Factor VII Administration During Cardiac Surgery.
    Harper PC; Smith MM; Brinkman NJ; Passe MA; Schroeder DR; Said SM; Nuttall GA; Oliver WC; Barbara DW
    J Cardiothorac Vasc Anesth; 2018 Feb; 32(1):151-157. PubMed ID: 29217234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coagulation management with factor concentrates in liver transplantation: a single-center experience.
    Kirchner C; Dirkmann D; Treckmann JW; Paul A; Hartmann M; Saner FH; Görlinger K
    Transfusion; 2014 Oct; 54(10 Pt 2):2760-8. PubMed ID: 24827116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Prothrombin Complex Concentrate on Blood Use, Cost, and Outcomes in Heart Transplantation.
    Wu DW; Xia Y; Uelinger J; Forest S; Szymanski J; Mohandas K; Walsh R; Karim S; Marks E; Himchak E; Gupta R; Goldstein D
    Ann Thorac Surg; 2018 Apr; 105(4):1152-1157. PubMed ID: 29397934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery.
    Ranucci M; Baryshnikova E; Crapelli GB; Rahe-Meyer N; Menicanti L; Frigiola A;
    J Am Heart Assoc; 2015 Jun; 4(6):e002066. PubMed ID: 26037084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of prothrombin complex concentrate for management of coagulopathy after cardiac surgery: a propensity score matched comparison to plasma.
    Fitzgerald J; Lenihan M; Callum J; McCluskey SA; Srinivas C; van Rensburg A; Karkouti K
    Br J Anaesth; 2018 May; 120(5):928-934. PubMed ID: 29661410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Fresh-Frozen Plasma, Four-Factor Prothrombin Complex Concentrates, and Recombinant Factor VIIa to Facilitate Procedures in Critically Ill Patients with Coagulopathy from Liver Disease: A Retrospective Cohort Study.
    Kwon JO; MacLaren R
    Pharmacotherapy; 2016 Oct; 36(10):1047-1054. PubMed ID: 27547916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.